Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
$1.1M Buy
35,957
+2,450
+7% +$77.1K 0.57% 54
2015
Q3
$999K Sell
33,507
-210
-0.6% -$6.73K 0.54% 55
2015
Q2
$1.07M Sell
33,717
-1,147
-3% -$37.4K 0.52% 57
2015
Q1
$1.15M Sell
34,864
-527
-1% -$16.8K 0.55% 53
2014
Q4
$1.05M Hold
35,391
0.49% 53
2014
Q3
$993K Sell
35,391
-1,131
-3% -$31.7K 0.49% 55
2014
Q2
$1.03M Hold
36,522
0.5% 59
2014
Q1
$1.11M Sell
36,522
-31
-0.1% -$924 0.58% 54
2013
Q4
$1.06M Sell
36,553
-1,897
-5% -$55.2K 0.55% 53
2013
Q3
$1.05M Sell
38,450
-300
-0.8% -$8.16K 0.59% 52
2013
Q2
$1.03M Buy
+38,750
New +$1.07M 0.6% 52

Other funds holding PFE

Taylor Cottrill's PFE Position: Q4 2015 in Review

Taylor Cottrill increased its Pfizer (PFE) stake by 7.3% in Q4 2015, buying an estimated $77.1K and bringing the position to 35,957 shares worth $1.1M. The position accounts for 0.57% of the portfolio, ranked #54.

Taylor Cottrill first reported a position in PFE in Q2 2013 and has held it in 11 quarters since. The position peaked at $1.15M in Q1 2015. 1,970 funds tracked by Wall St. Rank hold PFE as of Q4 2015.

  • Taylor Cottrill held 35,957 shares of Pfizer worth $1.1M as of Q4 2015.
  • Taylor Cottrill bought 2,450 Pfizer shares in Q4 2015, an estimated $77.1K.
  • Pfizer made up 0.57% of Taylor Cottrill's portfolio in Q4 2015, its #54 holding.
  • Taylor Cottrill first reported a position in Pfizer in Q2 2013 and has held it in 11 quarters since.
  • Taylor Cottrill's Pfizer position peaked at $1.15M in Q1 2015.
  • 1,970 funds tracked by Wall St. Rank held Pfizer as of Q4 2015.

Based on Taylor Cottrill's 13F filing for Q4 2015, filed 5 Feb 2016.